In the present study, we showed that MCC950, a specific small molecule inhibitor of NLRP3, significantly decreased the overall mortality of NEC mouse model, reduced pro-inflammatory cytokine expression (mature IL-1β, IL-6, and TNF-α), and greatly ameliorated the severity of histological damage in the intestine of NEC mice. This evidence concerns the gene TNF and necrotizing enterocolitis.